Detalles de la búsqueda
1.
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study.
Gynecol Oncol
; 175: 182-189, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37355448
2.
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study.
Int J Gynecol Cancer
; 31(7): 1031-1036, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33990353
3.
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome.
Gynecol Oncol
; 156(1): 38-44, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31699415
4.
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel.
Support Care Cancer
; 28(5): 2435-2442, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32048043
5.
A new founder BRCA1 haplotype identified in the Puglia region is associated with a specific age-related cancer onset in three unrelated families.
Clin Chem Lab Med
; 59(3): e95-e98, 2021 02 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32396136
6.
Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health.
Oncotarget
; 15: 134-141, 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38386807
7.
First-line cetuximab + platinum-based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real-world observational study-ENCORE.
Cancer Rep (Hoboken)
; 6(5): e1804, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37069784
8.
Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.
Front Oncol
; 13: 1247291, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37781174
9.
Corrigendum: Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.
Front Oncol
; 13: 1357793, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38318323
10.
Management of Metastatic Endometrial Cancer: Physicians' Choices Beyond the First Line. A MITO Survey.
Front Oncol
; 12: 880008, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35692798
11.
The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need Trial.
Vaccines (Basel)
; 8(2)2020 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32326034
12.
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status.
J Ovarian Res
; 12(1): 9, 2019 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30691488
13.
Selection of systemic therapy in patients with locally advanced and recurrent/metastatic head and neck cancer: RAND-based expert opinion by an Italian multidisciplinary panel.
Tumori
; : 300891619868289, 2019 Aug 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31462160
14.
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study.
Eur J Surg Oncol
; 44(7): 1062-1068, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29753611
15.
Weekly administration of paclitaxel: theoretical and clinical basis.
Crit Rev Oncol Hematol
; 44 Suppl: S3-13, 2002 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-12505595
Resultados
1 -
15
de 15
1
Próxima >
>>